1. Home
  2. SSKN vs AYTU Comparison

SSKN vs AYTU Comparison

Compare SSKN & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSKN
  • AYTU
  • Stock Information
  • Founded
  • SSKN 1989
  • AYTU N/A
  • Country
  • SSKN United States
  • AYTU United States
  • Employees
  • SSKN N/A
  • AYTU N/A
  • Industry
  • SSKN Medical/Dental Instruments
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSKN Health Care
  • AYTU Health Care
  • Exchange
  • SSKN Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • SSKN 14.5M
  • AYTU 15.0M
  • IPO Year
  • SSKN 2005
  • AYTU N/A
  • Fundamental
  • Price
  • SSKN $2.93
  • AYTU $2.26
  • Analyst Decision
  • SSKN
  • AYTU
  • Analyst Count
  • SSKN 0
  • AYTU 0
  • Target Price
  • SSKN N/A
  • AYTU N/A
  • AVG Volume (30 Days)
  • SSKN 14.7K
  • AYTU 32.2K
  • Earning Date
  • SSKN 11-12-2024
  • AYTU 11-12-2024
  • Dividend Yield
  • SSKN N/A
  • AYTU N/A
  • EPS Growth
  • SSKN N/A
  • AYTU N/A
  • EPS
  • SSKN N/A
  • AYTU N/A
  • Revenue
  • SSKN $32,729,999.00
  • AYTU $81,002,000.00
  • Revenue This Year
  • SSKN N/A
  • AYTU N/A
  • Revenue Next Year
  • SSKN $8.71
  • AYTU N/A
  • P/E Ratio
  • SSKN N/A
  • AYTU N/A
  • Revenue Growth
  • SSKN N/A
  • AYTU N/A
  • 52 Week Low
  • SSKN $2.51
  • AYTU $2.11
  • 52 Week High
  • SSKN $7.10
  • AYTU $3.50
  • Technical
  • Relative Strength Index (RSI)
  • SSKN 51.24
  • AYTU 42.19
  • Support Level
  • SSKN $2.58
  • AYTU $2.11
  • Resistance Level
  • SSKN $2.88
  • AYTU $2.44
  • Average True Range (ATR)
  • SSKN 0.24
  • AYTU 0.13
  • MACD
  • SSKN 0.01
  • AYTU -0.02
  • Stochastic Oscillator
  • SSKN 57.14
  • AYTU 20.27

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

Share on Social Networks: